CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Open-market sale Felsch Robert Ora sold 1,048 shares at $3.55 ($3,722)
- 4 Open-market sale Blanks Robert sold 2,846 shares at $3.55 ($10,108)
- 4 Open-market sale Chief Medical Officer sold 25,000 shares at $3.35 ($83,633)
- 4 Planned sale Blanks Robert sold 33,333 shares at $3.63 ($121,042)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 12,755 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 12,755 shares (grant or award)
- 4 Grant or award Director acquired 18,494 shares (grant or award)
- 4 Grant or award Director acquired 16,581 shares (grant or award)
- 4 Grant or award Director acquired 25,510 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Felsch Robert Ora sold 1,046 shares at $3.65 ($3,821)
- 4 Open-market sale President & CEO sold 11,357 shares at $3.65 ($41,489)
- 4 Open-market sale GRAMMER ELIZABETH A sold 2,384 shares at $3.65 ($8,709)
- 4 Open-market sale Blanks Robert sold 2,835 shares at $3.65 ($10,357)
- 4 Open-market sale Chief Financial Officer sold 2,873 shares at $3.65 ($10,496)
- 4 Open-market sale Chief Commercial Officer sold 4,711 shares at $3.65 ($17,210)
- 4 Open-market sale Chief Development Officer sold 3,769 shares at $3.65 ($13,769)
- 4 Open-market sale Chief Medical Officer sold 2,583 shares at $3.65 ($9,436)
Page 12 of 35 · 696 filings